Ventilator-induced lung injury in preterm infants;Lesão pulmonar induzida pela ventilação em recém-nascidos prematuros

Revista Brasileira de Terapia Intensiva

Volumn 25, Issue 4, 2013, Pages 319-326

  Carvalho, Clarissa Gutierrez ^a,b   Silveira, Rita C ^a,b   Procianoy, Renato Soibelmann ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Artificial; Bronchopulmonary dysplasia; Continuous positive airway pressure; Cytokines; Infant; Preterm; Respiration; Ventilator induced lung injury

Indexed keywords

CYTOKINE; LUNG SURFACTANT;

ADVERSE EFFECTS; ANIMAL; ARTIFICIAL VENTILATION; BRONCHOPULMONARY DYSPLASIA; HUMAN; INFLAMMATION; METABOLISM; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PROCEDURES; TIDAL VOLUME; TIME; VENTILATOR-INDUCED LUNG INJURY;

ANIMALS; BRONCHOPULMONARY DYSPLASIA; CONTINUOUS POSITIVE AIRWAY PRESSURE; CYTOKINES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; TIDAL VOLUME; TIME FACTORS; VENTILATOR-INDUCED LUNG INJURY;

EID: 84898647396     PISSN: 0103507X     EISSN: 19824335     Source Type: Journal    
DOI: 10.5935/0103-507X.20130054     Document Type: Review

References (52)

1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723-9.
2. Rebello CM, Proença RS, Troster EJ, Jobe AH Terapia com surfactante pulmonar exógeno - o que é estabelecido e o que precisamos determinar. J Pediatr (Rio J). 2002;78(Supl 2):S215-26.
3. Melville JM, Moss TJ The immune consequences of preterm birth. Front Neurosci. 2013;7:79.
4. Lista G, Castoldi F, Fontana P, Reali R, Reggiani A, Bianchi S, et al. Lung inflammation in preterm infants with respiratory distress syndrome: effects of ventilation with different tidal volumes. Pediatr Pulmonol. 2006;41(4):357-63.
5. Kotecha S, Silverman M, Shaw RJ, Klein N. Soluble L-selectin concentration in bronchoalveolar lavage fluid obtained from infants who develop chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed. 1998;78(2):F143-7.
6. Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 1995;72(2):F90-6.
7. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174(5):1209-20.
8. Beresford MW, Shaw NJ Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. Pediatr Res. 2002;52(6):973-8.
9. Kramer BW, Kallapur S, Newnham J, Jobe AH Prenatal inflammation and lung development. Semin Fetal Neonatal Med. 2009;14(1):2-7.
10. Frank JA, Parsons PE, Matthay MA Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest. 2006;130(6):1906-14.
11. Allison BJ, Crossley KJ, Flecknoe SJ, Davis PG, Morley CJ, Harding R, et al. Ventilation of the very immature lung in utero induces injury and BPD-like changes in lung structure in fetal sheep. Pediatr Res. 2008;64(4):387-92.
12. Kotecha S, Wangoo A, Silverman M, Shaw RJ Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr. 1996;128(4):464-9.
13. Nakanishi H, Sugiura T, Streisand JB, Lonning SM, Roberts JD Jr. TGF-beta neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung. Am J Physiol Lung Cell Mol Physiol. 2007;293(1):L151-61.
14. Auten RL, Richardson RM, White JR, Mason SN, Vozzelli MA, Whorton MH Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats. J Pharmacol Exp Ther. 2001;299(1):90-5.
15. Quinn DA, Mouffarrej RK, Volokhow A, Hales CA Interactions of lung stretch, hyperoxia, and MIP-2 production in ventilator-induced lung injury. J Appl Physiol. 2002;93(2):517-25.
16. Hillman NH, Moss TJ, Kallapur SG, Bachurski C, Pillow JJ, Polglase GR, et al. Brief, large tidal volume ventilation initiates lung injury and a systemic response in fetal sheep. Am J Respir Crit Care Med. 2007;176(6):575-81.
17. Capoluongo E, Vento G, Santonocito C, Matassa PG, Vaccarella C, Giardina B, et al. Comparison of serum levels of seven cytokines in premature newborns undergoing different ventilatory procedures: high frequency oscillatory ventilation or synchronized intermittent mandatory ventilation. Eur Cytokine Netw. 2005;16(3):199-205.
18. Wrigge H, Zinserling J, Stüber F, von Spiegel T, Hering R, Wetegrove S, et al. Effects of mechanical ventilation on release of cytokines into systemic circulation in patients with normal pulmonary function. Anesthesiology. 2000;93(6):1413-7.
19. Bohrer B, Silveira RC, Neto EC, Procianoy RS Mechanical ventilation of newborns infant changes in plasma pro-and anti-inflammatory cytokines. J Pediatr. 2010;156(1):16-9.
20. Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med. 1998;157(1):294-323.
21. Auten RL, Vozzelli M, Clark RH Volutrauma. What is it, and how do we avoid it? Clin Perinatol. 2001;28(3):505-15.
22. Wallace MJ, Probyn ME, Zahra VA, Crossley K, Cole TJ, Davis PG, et al. Early biomarkers and potential mediators of ventilation-induced lung injury in very preterm lambs. Respir Res. 2009;10:19.
23. Stenson BJ, Boyle DW, Szyld EG Initial ventilation strategies during newborn resuscitation. Clin Perinatol. 2006;33(1):65-82, vi-vii.
24. Froese AB, McCulloch PR, Sugiura M, Vaclavik S, Possmayer F, Moller F. Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Am Rev Respir Dis. 1993;148(3):569-77.
25. Imai Y, Parodo J, Kajikawa O, de Perrot M, Fischer S, Edwards V, et al. Injurius mechanical ventilation and end-organ ephitelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA. 2003;289(16):2104-12.
26. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest. 1997;99(5):944-52
27. Hillman NH, Kemp MW, Noble PB, Kallapur SG, Jobe AH Sustained inflation at birth did not protect preterm fetal sheep from lung injury. Am J Physiol Lung Cell Mol Physiol. 2013;305(6):L446-53
28. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB; COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008;358(7):700-8.
29. Erratum in N Engl J Med. 2008;358(14):1529.
30. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362(21):1970-9.
31. Erratum in N Engl J Med. 2010;362(23):2235
32. Tapia JL, Urzua S, Bancalari A, Meritano J, Torres G, Fabres J, Toro CA, Rivera F, Cespedes E, Burgos JF, Mariani G, Roldan L, Silvera F, Gonzalez A, Dominguez A; South American Neocosur Network. Randomized trial of early bubble continuous positive airway pressure for very low birth weight infants. J Pediatr. 2012;161(1):75-80.
33. Aly H, Milner JD, Patel K, El-Mohandes AA. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants? Pediatrics. 2004;114(3):697-702.
34. Te Pas A.B., Lopriore E, Engbers MJ, Walther FJ Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study. PloS One. 2007;2(2):e192
35. Finer N, Carlo WA, Duara S, Fanaroff AA, Donovan ER Wright LL, Kandefer S, Poole WK; National Institute of Child Health and Human Development Neonatal Research Network. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics. 2004;114(3):651-7.
36. Stevens TR Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007;(4):CD003063.
37. Jobe AH, Kramer BW, Moss TJ, Newham JP, Ikegami M. Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs. Pediatr Res. 2002;52(3):387-92
38. Polglase GR, Hillman NH, Ball MK, Kramer BW, Kallapur SG, Jobe AH, et al Lung and systemic inflammation in preterm lambs on continuous positive airway pressure or conventional ventilation. Pediatr Res. 2009;65(1):67-71
39. Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev. 2003;(2):CD000143. Review.
40. Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed. 2011;96(4):F243-8.
41. Owen LS, Marley CJ, Davis PG Neonatal nasal intermittent positive pressure ventilation: what do we know in 2007? Arch Dis Child Fetal Neonatal Ed. 2007;92(5):F414-8
42. Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study. J Pediatr. 2007;150(5):521-6, 526.e1
43. Sai Sunil Kishore M, Dutta S, Kumar P. Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome. Acta Paediatr. 2009;98(9):1412-5.
44. Bhandari V, Gavino RG, Nedrelow JH, Pallela P, Salvador A, Ehrenkranz RA, et al. A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS. J Perinatol. 2007;27(11):697-703
45. Bhandari V, Finer NN, Ehrenkranz RA, Saha S, Das A, Walsh MC, Engle WA, Van Meurs KP; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Synchronized nasal intermittent positive-pressure ventilation and neonatal outcomes. Pediatrics. 2009;124(2):517-26.
46. Meneses J, Bhandari V, Alves JG, Herrmann D. Noninvasive ventilation for respiratory distress syndrome: a randomized controlled trial. Pediatrics. 2011;127(2):300-7.
47. Lista G, Castoldi F, Fontana P, Daniele I, Cavigioli F, Rossi S, et al. Nasal continuous positive airway pressure (CPAP) versus bi-level nasal CPAP in preterm babies with respiratory distress syndrome: a randomized control trial. Arch Dis Child Fetal Neonatal Ed. 2010;95(2):F85-9.
48. Courtney SE, Durand DJ, Asselin JM, Hudak ML, Aschner JL, Shoemaker CT; Neonatal Ventilation Study Group. High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants. N Engl J Med. 2002;347(9):643-52.
49. Dani C, Bertini G, Pezzati M, Filippi L, Pratesi S, Caviglioli C, et al. Effects of pressure support ventilation plus volume guarantee vs. high-frequency oscillatory ventilation on lung inflammation in preterm infants. Pediatr Pulmonol. 2006;41(3):242-9.
50. van Kaam A.H., Rimensberger PC Lung-protective ventilation strategies in neonatology: what do we know-what do we need to know? Crit Care Med. 2007;35(3):925-31
51. Wheeler KI, Klingenberg C, Morley CJ, Davis PG Volume-targeted versus pressure-limited ventilation for preterm infants: a systematic review and meta-analysis. Neonatology. 2011;100(3):219-27. Review.
52. van Kaam A.H., Rimensberger PC, Borensztajn D, De Jaegere AP; Neovent Study Group. Ventilation practices in the neonatal intensive care unit: a cross-sectional study. J Pediatr. 2010;157(5):767-71. e1-3.